Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels

Introduction: Bovine mucosal heparins (BMH) are currently being developed for re-introduction for both medical and surgical indications. BMH active pharmaceutical ingredient (API) exhibits a somewhat weaker USP potency when compared to PMHs. We hypothesized that when dosages are normalized based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeske, Walter, Kouta, Ahmed, Farooqui, Ambar, Siddiqui, Fakiha, Rangnekar, Varun, Niverthi, Manoj, Laddu, Rajan, Hoppensteadt, Debra, Iqbal, Omer, Walenga, Jeanine, Fareed, Jawed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333674/
https://www.ncbi.nlm.nih.gov/pubmed/30687709
http://dx.doi.org/10.3389/fmed.2018.00360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333674/
https://www.ncbi.nlm.nih.gov/pubmed/30687709
http://dx.doi.org/10.3389/fmed.2018.00360

Ejemplares similares